Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-005574
Filing Date
2021-04-14
Accepted
2021-04-14 17:18:42
Documents
19
Period of Report
2021-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp149376_6k.htm 6-K 11692
2 EXHIBIT 99.1 dp149376_ex9901.htm EX-99.1 64123
3 GRAPHIC image_002.jpg GRAPHIC 7346
4 GRAPHIC image_001.jpg GRAPHIC 9975
5 EXHIBIT 99.2 dp149376_ex9902.htm EX-99.2 1969
6 GRAPHIC ex9902_1.jpg GRAPHIC 141299
7 GRAPHIC ex9902_2.jpg GRAPHIC 482998
8 GRAPHIC ex9902_3.jpg GRAPHIC 472696
9 GRAPHIC ex9902_4.jpg GRAPHIC 184282
10 EXHIBIT 99.3 dp149376_ex9903.htm EX-99.3 2006
11 GRAPHIC ex9903_1.jpg GRAPHIC 188966
12 GRAPHIC ex9903_2.jpg GRAPHIC 248955
13 GRAPHIC ex9903_3.jpg GRAPHIC 484388
14 GRAPHIC ex9903_4.jpg GRAPHIC 286208
15 EXHIBIT 99.4 dp149376_ex9904.htm EX-99.4 2150
16 GRAPHIC ex9904_1.jpg GRAPHIC 47853
17 GRAPHIC ex9904_2.jpg GRAPHIC 211326
18 GRAPHIC ex9904_3.jpg GRAPHIC 493658
19 GRAPHIC ex9904_4.jpg GRAPHIC 291146
  Complete submission text file 0000950103-21-005574.txt   4976065
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 21826454
SIC: 2834 Pharmaceutical Preparations